~~<i id='518E61ECE3'><strike id='518E61ECE3'><tt id='518E61ECE3'><pre id='518E61ECE3'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

author：fashion 2025-09-29 21:28:05 - browse：77

A device component from Paradromics Inc., one of the main brain-computer interface players racing to get to market. Courtesy Paradromics Inc.

Rodney Gorham loves fast, flashy cars: His WhatsApp profile picture is a bright yellow Corvette Stingray. “I don’t get to drive it anymore,” Gorham told STAT in a text.

Gorham, a 63-year-old living in Australia, has amyotrophic lateral sclerosis. He can’t speak, and can move his hands and legs only a little. But he is able to control his computer with his thoughts, aided by a brain-computer interface developed by the startup Synchron.

“It has been exciting to be involved,” Gorham wrote.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： The Harvard botanist who searched for psychedelics in the Amazon

focus

leisure time

hotspot

focus

"Arrestingcancer."ADAMFEUERSTEIN/STATYou’rereadingthewebeditionofASCOin30Seconds,STAT’sguidetotheAme

WSS

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Shifting the focus from loneliness to social health

HIV drugs protect against transmission, even in unprotected sex

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Shifting the focus from loneliness to social health

Why palliative psychiatry is worth discussing

leisure time

leisure time

focus

Affirmative action in medical school literally saved lives

Community Health Systems hospitals under DOJ investigation

Dobbs anniversary: the lost opportunity of abortion as health care

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Virginia high school admissions case could be legal follow

Intellia reports positive results for its CRISPR

Novavax promises a turnaround & Lilly roils the obesity market

The Pandemic Treaty must support building strong health systems

New air purifier tech could be key to improving indoor air quality

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

focus

R1 RCM gets $5.8 billion buyout offer from private equity firm

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Ed Silverman on new gene therapies, biosimilars, coffee, and more

PBM reform efforts get punted in Congress

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

leisure time

hotspot

focus

focus